These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38814653)

  • 1. A neutrophil variant with dotlike eosinophilic granules in a child with transient abnormal myelopoiesis of Down syndrome.
    Kahwash SB
    Blood; 2024 May; 143(22):2336. PubMed ID: 38814653
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome.
    Yamato G; Deguchi T; Terui K; Toki T; Watanabe T; Imaizumi T; Hama A; Iwamoto S; Hasegawa D; Ueda T; Yokosuka T; Tanaka S; Yanagisawa R; Koh K; Saito AM; Horibe K; Hayashi Y; Adachi S; Mizutani S; Taga T; Ito E; Watanabe K; Muramatsu H
    Leukemia; 2021 May; 35(5):1480-1484. PubMed ID: 33654203
    [No Abstract]   [Full Text] [Related]  

  • 3. Mirror syndrome associated with fetal transient abnormal myelopoiesis in Down syndrome.
    Kobayashi Y; Miyoshi T; Matsuyama TA; Miyauchi J; Miyashita T; Ishibashi-Ueda H; Yoshimatsu J
    Pathol Int; 2015 Aug; 65(8):443-5. PubMed ID: 25808295
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombocytosis in a newborn with Down syndrome and transient abnormal myelopoiesis.
    Fujihara I; Yanagisawa R; Fukushima Y; Komori K; Ogiso Y; Sakashita K
    Br J Haematol; 2016 Feb; 172(3):314. PubMed ID: 26457464
    [No Abstract]   [Full Text] [Related]  

  • 5. Basophilic differentiation in transient abnormal myelopoiesis.
    Bain BJ
    Am J Hematol; 2016 Aug; 91(8):847. PubMed ID: 27192361
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous resolution of transient abnormal myelopoiesis between 34 and 40 weeks gestation.
    Maracaja DLV; Rinder H
    Br J Haematol; 2020 Feb; 188(4):481. PubMed ID: 31815289
    [No Abstract]   [Full Text] [Related]  

  • 7. Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis.
    Kuo E; Kumarapeli AR
    Arch Pathol Lab Med; 2020 Mar; 144(3):388-393. PubMed ID: 30969155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
    Miyauchi J
    Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisomy 21, transposition of the great arteries and abnormal myelopoiesis.
    Mishra C; Kadiyani L; Ramakrishnan S; Sehgal T
    Cardiol Young; 2022 Jan; 32(1):142-143. PubMed ID: 35034684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome.
    Sah RR; Ray S; Bhatia P; Dhir SK; Totadri S; Kumar N; Kumar P
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e292-e295. PubMed ID: 31876781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twin-to-twin transmission of transient abnormal myelopoiesis without constitutional trisomy 21: A case report.
    Roseman AS; Blackburn PR; Bakshi S; Grady L; Abbott MA; Hassan S; Hunt J; Richardson M; Peterson JF; Nguyen P; Greipp PT; Singh R
    Cancer Genet; 2020 Jun; 244():62-64. PubMed ID: 32464589
    [No Abstract]   [Full Text] [Related]  

  • 12. Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with
    Nishinaka-Arai Y; Niwa A; Matsuo S; Kazuki Y; Yakura Y; Hiroma T; Toki T; Sakuma T; Yamamoto T; Ito E; Oshimura M; Nakahata T; Saito MK
    Haematologica; 2021 Feb; 106(2):635-640. PubMed ID: 32354872
    [No Abstract]   [Full Text] [Related]  

  • 13. [Abnormal hematopoiesis in Down syndrome].
    Ito E
    Rinsho Ketsueki; 2014 Oct; 55(10):1738-47. PubMed ID: 25297735
    [No Abstract]   [Full Text] [Related]  

  • 14. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
    Toki T; Kanezaki R; Kobayashi E; Kaneko H; Suzuki M; Wang R; Terui K; Kanegane H; Maeda M; Endo M; Mizuochi T; Adachi S; Hayashi Y; Yamamoto M; Shimizu R; Ito E
    Blood; 2013 Apr; 121(16):3181-4. PubMed ID: 23440243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient abnormal myelopoiesis (TAM) in a neonate without Down syndrome.
    Bidet A; Dulucq S; Aladjidi N
    Br J Haematol; 2015 Jan; 168(1):2. PubMed ID: 25308890
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver fibrosis with hypereosinophilia causing transient abnormal myelopoiesis.
    Minakata S; Sakata N; Wada N; Konishi Y; Marutani S; Enya T; Nakagawa H; Wada H; Takemura T
    Pediatr Int; 2016 Nov; 58(11):1222-1225. PubMed ID: 27709778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recalcitrant transient abnormal myelopoiesis in neonatal Down syndrome.
    Timmis S; Hodder A; Bharadwaj N; Inglott S; Chalker J; Cheng D; Tandon S; Bartram J
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29662. PubMed ID: 35293681
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of trisomy 21 on early human hematopoiesis.
    Roy A; Cowan G; Vyas P; Roberts I
    Cell Cycle; 2013 Feb; 12(4):533-4. PubMed ID: 23343767
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective diagnosis of transient abnormal myelopoiesis by using preserved dried umbilical cord.
    Okamoto T; Nagaya K; Toriumi N; Sarashina T; Azuma H
    Pediatr Int; 2021 Oct; 63(10):1243-1245. PubMed ID: 34219329
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
    Bhatnagar N; Nizery L; Tunstall O; Vyas P; Roberts I
    Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.